Author： Hughes Dyfrig A.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.29, Iss.9, 2011-09, pp. : 731-735
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bortezomib: one step closer to value-based pricing?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 533, 2007-01 ,pp. :
Access to resources
Recommend
Does Direct-to-Consumer Advertising of Antidepressants Lead to a Net Social Benefit?
PharmacoEconomics, Vol. 26, Iss. 7, 2008-01 ,pp. :
On-treatment apolipoprotein levels: predictive benefit?
Inpharma, Vol. 1, Iss. 1271, 2001-01 ,pp. :
Can tumour response predict a survival benefit?
Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. :